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Further studies on the response of intestinal crypt cells of different
hierarchical status to eighteen different cytotoxic agents
K. Ijiril & C.S. Potten2
'Zoological Institute, Faculty ofScience, University ofTokyo, Hongo, Tokyo 113, Japan and 2Paterson Institutefor Cancer
Research, Christie Hospital & Holt Radium Institute, Manchester, M20 9BX, UK.
Summary Adult male mice were treated with one or two different doses of each of 18 different cytotoxic
agents. They were sampled at various times (3-12h) thereafter, and the spatial distributions of cell death in
the small intestinal crypts were studied. Dead or dying cells or cells carrying dead cell fragments were
examined histologically, and all of these were recorded (for convenience as apoptotic fragments), relative to
the cell position in the crypt. Thus, distributions of apoptotic fragments against cell position were determined.
A regression analysis of the data obtained at different times after administration of each agent was
undertaken and the position of the median of the spatial distribution of presumptive target cells was deduced
for each cytotoxic agent. The accuracy of this median value was determined to be ±0.5 cell positions. From
these median values, the different cytotoxic agents could be divided roughly into three groups: [3H]-thymidine,
isopropyl-methane-sulphonate, gamma-rays, bleomycin and adriamycin all have their median values (suscep-
tible cells) at cell positions 4 to 6; bischlorethylnitrosourea, actinomycin D, cyclophosphamide and cyclo-
heximide at cell positions 6-8; mechlorethamine, triethylenethiophosphoramide, vincristine, 5-fluorouracil,
hydroxyurea and methotrexate at cell positions 8-11. The position of these medians was considered in
relation to the killing of clonogenic cells. Preliminary studies on the distributions of dead cells after myleran,
cis-platinum and heat (hyperthermia) were also reported.
There is a general tendency for antibiotics and radiation to attack the lower cell positions in the crypt.
Alkylating agents on the other hand have a somewhat broad spectrum of action. Antimetabolites and a
microtubule dissociating agent act on higher cell positions. No difference could be detected between two
different forms (sources) of actinomycin D. The changes in the yields of apoptotic and mitotic cells with time
and the migration velocities of cells in the crypts carrying apoptotic fragments after exposure to cytotoxics are
also presented.
In a previous paper (Ijiri & Potten, 1983) the response of the and dilutions were carried out either in 0.9% saline or in
small intestinal crypt of the mouse to various cytotoxic sterile water (except for myleran and cis-platinum, which
agents was analysed and a heterogeneous cellular composition were dissolved in arachis oil). All injections (0.1-0.2ml) were
in the crypt was indicated. The results clearly showed that given i.p. at 09.00h. Drug does injected in this volume are
each cytotoxic agent tended to act preferentially upon a quoted as mg per mouse (1 mg per mouse is 40mg kg-1).
characteristically positioned band of cells up the side of the Whole-body irradiation was achieved using a 137Cs-gamma-
crypt. Since cell position in the crypt is likely to be related to irradiator at a dose rate of 4.5Gymin-1. Irradiation was
the hierarchical status within a cell lineage, each agent performed between 09.00-09.30h. Hyperthermia (44°C,
appeared to have some selectivity for cells of a particular 30min) was achieved at 09.00-09.30h by hot-bath immersion
hierarchical status. The cytotoxic impact of a given agent of an exteriorized loop of small intestine, as described by
was determined by counting the number of dead or dying Hume et al. (1979).
cells observed histologically (pycnotic or apoptotic cells).
However, in that paper the data for some of the drugs were
obtained using subtly different criteria. Detailed information Abbreviations anddrug source
on the changes with time in the number of dead cells and The treatments were as follows: [3H]TdR (tritiated
mitotic cells was not presented. This prevented a full analysis thymidine, Amersham Int.), BLM (bleomycin hydrochloride,
of the regression lines through the data obtained at different Nihon Kayaku, Tokyo), IMS (isopropyl-methane-sulphonate,
times after treatment and hence we could deduce neither the Koch-Light), ADR (adriamycin, Montedison), BCNU
cell migration rates, nor the position of the presumptive (bischlorethylnitrosourea, Bristol-Myers Pharmaceuticals),
target cells for each cytotoxic agent. ACT (actinomycin-D, purchased from Merck, Sharp and
Here, we extend the earlier data to cover 18 different Dohme, as Cosmegen (R) or from Sigma), CP (cyclo-
cytotoxic agents with a full time course analysis on each. phosphamide, WB Pharmaceuticals), CH (cycloheximide,
Sigma), HN2 (mechlorethamine, nitrogen mustard, Boots),
TEPA (triethylene-thiophosphoramide, thio-TEPA, Lederle),
Materials and methods 5FU (5-fluorouracil, Roche), HU (hydroxyurea, Sigma),
VCR (vincristine, Lilly), MTX (methotrexate, Lederle),
Animals CDDP (cis-diamminedichloroplatinum II; cis-platinum,
donated by Professor B.W. Fox), MY (myleran (R), busulphan, Male B6D2F1 mice ('~25g) were used when 10-12 weeks Buruh-W'cm) hea (hprhri;44C 0m)o
old., Th anml wer kep une a 12hdr(1.070), further details of some of the treatments see Ijiri and Potten 12 h light regimen, and were given food and water ad (1983).
libitum. Four animals were used per experimental point. Frsm gns(3]d,gmary,IS P H
. . ~~~~~~~~~~HU, VCR and MY), the distributions of apoptotic
Adminstraiono drus, raiatin andheatfragments reported earlier (Ijiri & Potten, 1983) were
All drug solutions were made up immediately before use, reanalysed. For some drugs (ADR, ACT, HN2 and 5FU)
new experiments have been conducted using identical pro-
Correspondence: K. Ijiri. cedures which in effect repeat the earlier experiments which
Received 25 June 1986; and in revised form, 6 October 1986. were obtained by courtesy of Dr J.V. Moore. Several new114 K. IJIRI & C.S. POTTEN
drugs (BLM, BCNU, TEPA, MTX and CDDP) and heat When two different doses were used a complete time course
have now been analysed and are included here. For three (3-12h) was obtained for one at least of the doses.
agents, gamma-rays, CP and HU, replicate experiments and The two methods of analysis for the apoptotic distri-
replicate scoring were performed to define the reproducibility butions are illustrated in Figure 1. One was to express the
and reliability of the techniques (see Appendix A). The percentage of the total apoptotic fragments in various
changes in the yield of apoptotic cells and mitotic cells with positional intervals of the crypt. Five intervals were generally
time are presented for all the 18 cytotoxic agents. used. The other involved statistical parameters (Xmed, lr, a,)
which were defined mathematically elsewhere (Ijiri & Potten,
Sample preparation, scoring ofapoptotic cells and the 1983). Briefly Xmed is the median cell position and a, a
determination ofthe distribution ofapoptoticfragments measure of the spread of the distribution to the right and a,
to the left. The second method was particularly useful since
Good longitudinal sections of crypts were selected i.e. crypts it treated the crypt cell positions as continuous values, which
showing some evidence of a lumen, some Paneth cells at the can be treated mathematically: crypt size correction can be
base and at least 17 cells along the side. Starting at the base applied easily and it also permits the back extrapolation of
of the crypt column the cells were numbered up each side the parameters to the estimated values at the time the agents
and the cell positions which included any apoptotic were given i.e. t=Oh. The first method however, visually
fragments were recorded. From these data a distribution of illustrates more clearly how each area in the crypt responds
the apoptotic yield against cell position was obtained. For to the cytotoxic agents, but it is more difficult to perform the
each experimental group, 100 to 400 half-crypts were scored, mathematical treatments when this method was used.
and each distribution consisted of 140'-900 apoptotic
fragments. The data on the reproducibility of apoptotic
fragments are shown in Appendix A. If one or more Back extrapolation ofthe median values of the apoptotic
apoptotic fragments were, from their size and clustering, distributions obtained at different times after treatment to
thought to represent the remains of a single cell, they were estimate the target cell population
recorded as a single apoptotic cell. This is clearly a sub- Figure 2 illustrates this approach. In the first instance, the
jective decision. For further details see Ijiri & Potten (1983, two parameters, the median (Xmed) and ar were calculated for
1984). each distribution of apoptotic fragments at each time after
the administration of an agent (see Figure 1). Figure 2a
shows a typical example of the relationship between Xmed
Methods ofanalysisfor the distribution ofapoptoticfragments and a, for the 3-12h data for one dose level of an agent. In
A typical example of an apoptotic frequency distribution is this example, at 6h, both Xmed and ar have larger values than
shown in Figure 1. Actual distributions for several agents are at 3h, which indicates a shift of the apoptotic distribution to
presented elsewhere (Ijiri & Potten, 1983). The number Of the right (i.e. towards the crypt top). The increase in a,
apoptotic fragments was recorded relative to the cell position means that cells in the upper part of the crypt move more
in the crypt (Figure 1). The agents tested, their doses, and rapidly than those in the lower part, causing the tail on the
the sampling times are listed in Table I. As a general rule, distribution to increase with time. In some cases, the 9h data
distributions were only analysed if the total average yield have a lower value of Xmed and a larger ar compared with the
exceeded 1.5 apoptotic cells per crypt section, i.e. were about 6h data. Similar changes may be noted for the 12h data.
10 times the control level. In this way, cell death caused by This is due to the fact that cell death and cell loss have
the cytotoxic agent was clearly distinguished from the shortened the crypt. After applying a correction for crypt
spontaneous level of cell death. size (described below), the pairs of coordinates (Xmed, r) in
At some time points for several agents (ACT, TEPA, Figure 2a appear as in Figure 2b. Both parameters now
5FU, MTX, CDDP and MY) the total average yield did not Increase steadily wlth increasing time.
exceed 1.5 apoptotic cells per crypt section. These sections When Xmed values obtained after crypt size correction are
were then scored for the distribution of apoptotic fragments plotted against time (Figure 2c), a least square linear
using selected crypts which contained many apoptoses. Such regression line can be fitted for the equation
data are indicated with the superscript 's' in Table I. They Xmed(t)=Vt+Xmed(0), the median can be back extrapolated to
were analysed in the same way as the rest of the data. In t=0 (Xmed(O)). The migration velocity v (expressed in cell
some cases where previous experiments had already positions h-1) can also be extracted as the slope of the line
accumulated sufficient data new samples were not obtained, (see Appendix B).
e.g. for 9 or 12h after the administration of some agents. Correctionfor crt size Corecton or ryptsz
A crypt size correction was achieved by multiplying each
15- E^>
15- Xmed value (Xmed or er,) by a factor (F) given by C/T where
Uo a1' (Jr ,l C =average number of cells to the top of the crypt in
. 10 ,luntreated control animals and T=the average number to the
top of the crypt in treated animals. C was taken as 24 cells,
Q- _ _ _ _ _ _the value used in the previous paper (Ijiri & Potten, 1983),
o i.e. the crypt length was standardised to 24 cell positions,
co 5- _which was also the approximate value for untreated animals
in the present experiments.
0O 10o 20 30
° ~ ~ ~~ ~Cell position Results
Interval [1-2] [3-61 [7-10][11-14] [15+] Apoptotic and mitoticfigures
Figure 1 Schematic illustration of the two methods of analysing Figure 3 shows the results for the number of apoptotic cells
the distributions of apoptotic fragments. One is to express the*
percentage of the total apoptotic fragments observed in various an mioi fiue.xrse e rytscina aiu
positional intervals of the crypt; five intervals in all; cell positions times (3-12h) after the administration of single doses of 18
1-2, 3-6, 7-10, 11-14 and 15 and beyond (15+). The other is to different cytotoxic agents. It has been reported that the
use statistical parameters (Xmed,err,er1) which have been defined mitotic yield in small intestinal crypts exhibits a circadian
mathematically elsewhere (Ijiri & Potten, 1983). rhythm (Sigdestad et al., 1969, Potten et al., 1977). A t-testRESPONSE OF INTESTINAL CRYPT CELLS TO CYTOTOXIC AGENTS 115
Table I Cytotoxic agents, range of doses and post-treatment sampling times and kinds of analysis for
apoptotic distributions
Time ofearliest Regression Regression
Time of sampling (h) after analysis for analysis for
C}totoxic Dose per sampling after administration target cell migration
agent used mouse administration (h) ofagenta positionb velocityc
[3H]TdR 50jCi 6, 6.5, 9, 12 6 + +
External- 0.5OGy 3* 3*
radiations 12.0Gy 3, 6, 9, 12 + +
y-ray 14.0Gy 3,6 + +
Two experiments using iy-rays, one using X-rays, two using neutrons were also analysed (for details, see
Ijiri & Potten, 1983)
BLM 0.5mg 3,6,9,12 3 + +
5.0mg 3, 6, 9, 12 3 + +
IMS 10.0mg 3, 6, 9, 12 3 + +
ADR 0.5mg 3, 6, 9, 12 3 + +
BCNU 0.25mg 9
2.5mg 6, 9, 12 6 + +
ACT
(Cosmegen) 0.01 mg 3S 6, 9, 12 3s + +
0.1mg 6
(Sigma) 0.01 mg 6
0.1mg 6
CP 1.0mg 9, 12 +
5.0mg 6* 6*
10.0mg 6, 9, 12 + +
CH 5.0mg 2, 3, 6, 12 2 + +
HN, 0.025mg 3, 6, 9, 12 3 + +
0.25mg 3, 6 3 + +
TEPA 0.025mg 9S, 12S +
0.25mg 6, 9, 12 6 + +
SFU 0.5mg 3s, 6 3S + +
5.0mg 3S,6,9, 12 3s + +
HU 1.0mg 3* 3*
1.0mg 3, 3.5, 6.5 +
10.0mg 3,4, 5, 6, 9, 12 + +
VCR 0.01 mg 6, 9, 12 +
0.1mg 3, 6, 9, 12 3 + +
MTX 1.5mg 9s, 12s +
15.0mg 6s,9, 12 6S + +
CDDP 0.1 mg 3s 6s 9s 3s + +
0.5mg 6S,9, 12S 6S + +
MY 1.0mg 6s, 9 12 6s + +
3.0mg 5.5 5.5
HEAT 44-C, 30min 3, 6, 9 3 + +
sData obtained by scoring selected crypts which contained many apoptotic cells: a total average ic(i
exceeding 1.5 apoptotic cells per crypt section; *The sampling time for pooled data using 16 mice (800
half-crypts), see Appendix A; aThe earliest time after administration of agent when the distribution of
apoptotic fragments was high enough to distinguish it from background (see text). These values have been
used in Figures 4 and 5 and Table II; bWhen a regression analysis was applied (indicated by a +) the
parameters for the target cell population were obtained by back extrapolation to t=0 or 3h. Such values
are shown in Table II and Figure 6; cWhen a regression analysis was applied (indicated by a +) the
migration velocity of the cells carrying apoptotic fragments can be calculated. The velocities for three
points on the distribution were estimated and are plotted in Figure 9.
For abbreviations of the names of cytotoxic agents, see text.
Drug doses are quoted as mg per mouse, and 1 mg per mouse is - 40mgkg1.
was applied to detect the time when the mitotic yield in the stathmokinetic agent, arresting cells at metaphase. Most of
treated mice was significantly below the yield in normal the arrested cells will eventually die. They do so in mitosis
animals at each time of the day. From the results of the and so differ from the other agents where death may occur
statistical test, the decrease in mitotic yield (dotted line in from other phases of the cell cycle. For convenience, cell
Figure 3) generally coincided with, or preceded, the rise in death induced by VCR has been loosely given the same term
apoptotic cells (solid line). Five agents were exceptions to (apoptosis). At early times after VCR administration,
this rule. For four of them ([3H]TdR, ACT, CDDP and apoptotic yield and mitotic yield rose in parallel. The results
MY), the decrease in the mitotic yield to values significantly after VCR are also presented in Figure 3c. In Figure 3, drug
lower than that in normal animals followed the rise in doses are quoted as mg per mouse, and 1lmg per mouse is
apoptotic yield. The other agent was VCR. This is a - 40 mg kg-1.116 K. IJIRI & C.S. POTTEN
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Figure 2 Illustration of the various steps involved in calculating the Xmed value at =Oh and the migration velocity for cells
carrying apoptotic fragments. (a): The Xmed-ra plot without any crypt size correction. The median (Xmed) and the measure of
spread (G,) calculated for each distribution of apoptotic fragments are shown. The figure beside each point shows the time (h) of
sampling after administration of agent. (b): The Xmed-a, plot after correction for differences in crypt size. In this example, the
following crypt size has been used as the average number of cells to the top of the crypt: 23.8 (3h), 23.4 (6h), 20.3 (9h) and 18.5
(12h). The crypt length is standardised to 24 cell positions. (c): Regression analysis for Xmcd(t). Xmed values after crypt size
correction are plotted against time t (h), and a simple linear regression by the least square method is applied. The line can be back
extrapolated to t=O, to give Xmed (0) at its intercept of the ordinate. The slope of the fitted line gives the migration velocity (cell
positions h-1) of median position of the apoptotic distributions. The average cell position where this velocity is assumed is taken
as the position given by Xmed (@I +t2)/2), shown as B in the figure, which corresponds to the average time A. The point A is
given by (tl +t2)/2 (see Appendix B). (d): The three points used for the calculation of migration velocity assuming a normal curve,
are Xmed, Xmed+0.674a, and Xmed + 1.177ar. The shaded area represents 25% of the total frequency (for details, see Appendix B).
The migration velocities for Xmed+O.674a, and Xmed+ 1.177a, are calculated in a similar manner as for Xmcd.
Analysis offive areas ofthe crypt (cellpositions 1-2, 3-6,
7-10, 11-14 and 15+)
Figure 4 shows the results of this type of approach (Figure 1
illustrates the position of the intervals studied). All doses and
times listed in Table I are included. The percentage values
shown by the actual letter for each agent in Figure 4 are
those from mice which were sampled at the earliest time
after administration of the agent, and therefore are likely to
be the closest to the distribution of the presumptive target
cell population at the time when each agent is acting. The
actual earliest sampling time(s) for each agent is indicated in
Table I (fourth column from the left) and also in Table II
(third column from the left) (3h or 6h after administration
for most agents, 2h for CH).
The cytotoxic agents are shown in Figure 4 in decreasing
order of the percentage of cell death in cell position 3-6
(from [3H]TdR to MTX). The data for cell position 3-6 is
roughly inversely correlated with the data for the percentage
of cell death at cell positions 11-14 and 15+. Three agents
(i.e. CDDP, MY and heat) have been plotted separately on
the right since these data were regarded as somewhat
preliminary.
Determination ofthe statistical parameters for the apoptotic
distributions
For the distribution obtained at the earliest time after
administration of each agent, the median (Xmed) and the
spread to the right (Tr) were determined and the medians are
listed in Table II. The Xmed (abscissa) and a, (ordinate) after
crypt size correction are plotted in Figure 5 using the same
letter coding as in Figure 4. For BLM, HN2 and 5FU, the
values shown in Figure 5 are the average for the two doses
studied. Each individual Xmed value but not a, is shown in
Table II (fifth column from left). Preliminary data have also
been obtained for three agents (not plotted in Figure 5): the
values for Xmcd and a, are respectively; CDDP (6.1, 6.0), MY
(6.3, 4.7) and heat (8.0, 8.7).
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Figure 3 a-c Changes in the yields of apoptotic cells (solid lines) and mitotic cells (dashed lines) per crypt section in the small
intestine at various times after single doses of 18 different cytotoxic agents. Four mice were used for each point and 50 crypt
sections were scored per mouse. When the data for two doses are shown, that for a larger dose is indicated by a solid circle (0)
and that for a smaller dose by a cross ( x ). Drug doses are quoted as mg per mouse, and 1 mg per mouse is -40mgkg-1. The
ordinate scales for the yield of mitotic cells are the same for all the agents except VCR, where the scale is ten times higher i.e. the
same as that for the apoptotic cells.
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25 '1-2] The back extrapolation of the median values to time zero 2 H 8 D F G P Q (t=O) to determine theposition ofthepresumptive target cells
O L | I H I i LLM N
H R Xmed values obtained 3-12h after treatment were used after
crypt size correction to estimate the Xmed value at t=Oh, by
50 back extrapolation to t=O as shown in Figure 2. For some
1 C E t P agents ([3H]TdR, BCNU, CP, TEPA, MTX and MY), the
25 14, J P R data available for the regression analysis began at 6h, in
01 e which case the data were also extrapolated back to t=3h.
The estimated values for Xmed at t=0, or t=3 h, and the time interval over which the regression was applied are listed in
E 50- [7-10] L Table II. The medians for the distribution of the target cells
m ii H t ? for each agent deduced in this way is shown in Figure 6.
o 25] c D PG II o When no distributions at 3h were obtained the mitotic yield
0 at 3h was studied (Figure 3), e.g. after BCNU and MTX the
a mitotic yield was significantly decreased compared with the
yield in normal animals taking into account the circadian
50- [11-14] rhythm (Welch's t-test). In contrast, the mitotic yields after
o 25 [3H]TdR, CP and TEPA were not significantly decreased at
1 25 -.3 IL 3 h. Thus, for BCNU and MTX, the drugs were assumed to
FK p I Ibe have had an effect by 3h (because the mitotic yield was
A t c E I O affected), and hence the Xmed values were back extrapolated
0 to t=0 h and these were plotted in Figure 6. [3H]TdR is
50- [15+] known to be incorporated into DNA within 30min, and
although the mitotic yield was not change at 3h, the Xmed
2L]L, was nevertheless obtained by back extrapolation to t=O and
5- 6 this was plotted in Figure 6. A slight increase in the
A i a i apoptotic yield at 3 h supported this decision. CP and TEPA ,,$c ?,F,H ,,, ,,,resulted in neither an increase in apoptotic yield, nor a
3HTdR BLM ADR ACT CH TEPA HU MTX CDDP HEAT decrease in mitotic yield, at 3 h and hence the Xmed value
XYn IMS BCNU CP HN2 5FU VCR MY back extrapolated to t=3 h was used for the Xmed for the
target cells. When the Xmed at t=0 could be obtained after
more than one dose of an agent, the average value was
Figure 4 Distribution of apoptotic fragments over five different chosen (y-ray BLM HN and 5FU).
intervals of cell positions in the crypt (see Figure 1). For each c ( B 2
agent, the range of values is shown by a vertical bar. The values Two different sources of ACT were used, one consisted of
shown by the actual symbol are those from mice which were the pure crystalline form of the chemical (Sigma) while the
sampled at the earliest time (3h or 6h) after administration of other was in a more soluble form for injection into patients
agent. The Xyn indicates external radiations such as X-rays, y- (Cosmegen (R): Merck, Sharp and Dohme). These were
rays and neutrons. compared 6h after administration and no differences could
Where two symbols exist it means that two doses were studied. be detected in the yield of apoptotic fragments and the
The points separated on the right represent preliminary data. position of the median (see Appendix A).
Back extrapolated to t=0 or 3h.
°] 5,,~~~~~~~~4.,ryp BCNUIII| HN2/% MTX Crypt
y B y-ray (standardised crypt)
XBC BLM C ,,
._ D IMS 0 0.2 0.3 0.4 1.0
6- 3 PADR (Normalised crypt)
q~ ~ ~ ~ ~ ~ ~ ~ ~ ~~~~~~~~ ~rp -F BCNUI H4MT rP
c M CD G G ACT Figure 6 Peak cell positions of the distributions of the
A CH presumptive target cells for different cytotoxic agents. The HJ j HN2 position of the median values (Xmed) back extrapolated to t=0
a.4- K K TEPA (as described in Figure 2c) are shown in standardised crypts. For
o 0~~~~~~~~~~~~~~~~~~~0 0.
tjn L L 5FU CP and TEPA, the median values were obtained by back
HU extrapolation to t=3h. These median values are listed in Table N VCR II. For y-ray, BLM, HN2 and 5FU, the average value of two
O MTX medians from two doses (Table II) is shown. The scale relating
2 actual cell positions to those in normalised crypts is also
4 6 8 10 12 presented.
Median of Apoptotic distribution Xmed
Figure 5 Parameters obtained from the distributions obtained at Discussion
the earliest time (either 3ph or 6oh) after administration of each
agent. For each apoptotic distribution, the median (Xmed) and a We have here been recording the number and position of
measure of the spread of the right half (r) have been calculated histologically-identifiable dead or dying cells. For some of
after crypt size correction. Symbols as for Figure 4. the agents used (radiation, ACT, CH) the timing andRESPONSE OF INTESTINAL CRYPT CELLS TO CYTOTOXIC AGENTS 119
Table II Median of earliest time distributions and of the distributions for the target cell population obtained by back extrapolation
Median position (Xmed) oftarget cell
population obtained by back
extrapolation ofregression lineb
Earliest time sample
Interval over which
Time ofearliest regression analysis
sampling after Xmed Xmed was applied (hours
Cytotoxic Dose per administration (uncorrected (corrected after administration Xmed Xmed
agent used mouse ofagent (h) for crypt size) for crypt size)' ofagent) (t=0) (t=3h)
[3H]TdR 50pCi 6 4.9 5.1 6-12 4.1 4.6
y-ray 0.50Gy 3* 6.1 6.4
12.0Gy 3-12 5.5
14.0Gy - - 3-6 5.2
BLM 0.5mg 3 5.2 5.3 3-12 5.2
5.0mg 3 5.8 5.9 3-12 5.5
IMS 10.0mg 3 5.8 5.7 3-12 4.9
ADR 0.5mg 3 5.4 5.7 3-12 5.4
BCNU 2.5mg 6 6.2 6.7 6-12 6.3 6.7
ACT
(Cosmegen) 0.01 mg 3s 6.4 6.8 3-12 6.6
CP 5.0mg 6* 7.6 8.1
10.0mg - 6-12 6.1 6.8
CH 5.0mg 2 7.7 7.3 2-12 7.1
HN2 0.025mg 3 8.3 8.6 3-12 8.5
0.25mg 3 7.3 7.8 3-6 8.0
TEPA 0.25mg 6 7.8 8.3 6-12 8.7 8.4
5FU 0.5mg 3s 8.8 9.1 3-6 8.9
5.0mg 3s 8.8 9.4 3-12 8.8
HU 1.0mg 3* 9.3 9.9
10.0mg 3-12 8.9
VCR 0.1 mg 3 9.7 9.8 3-12 8.8
MTX 15.0mg 6s 11.3 11.8 6-12 10.6 11.2
CDDP 0.1 mg 3s 6.3 6.1 3-9 5.5
0.5mg 6s 7.1 7.5 6-12 6.2 6.8
MY 1.0mg 6s 6.4 6.2 6-12 3.4 4.9
3.0mg 5.5 6.8 6.3 -
HEAT 44°C, 30min 3 8.4 8.0 3-9 6.9
sSame as in Table l; *Same as in Table I; aThe Xmed and ar values for the distribution sampled at the earliest time after
administration of an agent are plotted in Figure 5;bFrom these median values of the target cell distributions, the median for each
cytotoxic agent was determined after considering all the data (Figure 6).
For abbreviations of the names ofcytotoxic agents, see text.
Drug doses are quoted as mg per mouse, and I mg per mouse is -40mgkg-.
appearance of the dead or dying cells, both in the light and spatial distribution of presumptive target cells in the crypts
electron microscope, resembles the process of apoptosis at t=0 (or t=3 for CP and TEPA). The accuracy of each
(Searle et al., 1975; Potten, 1977, 1983; Wyllie, 1981). median value is +0.5 cell positions (see Appendix A). There
Cytosine arabinoside and mitomycin C also induce apoptosis are clear differences between the different drugs which seem
(Searle et al., 1975). For convenience we have adopted this to be divided roughly into three groups: (1) [3H]TdR, IMS,
terminology throughout, recognising that this is probably gamma-rays, BLM, ADR have their median values, i.e. peak
not correct in some cases (e.g. VCR). The dead or dying numbers of susceptible cells, at cell positions 4 to 6, (2)
cells recorded here include cells undergoing apoptosis, BCNU, ACT, CP, CH at cell positions 6-8, (3) HN2, TEPA,
pycnotic cells, degenerating mitotic figures, cells undergoing VCR, 5FU, HU and MTX in cell positions 8-11. The first
coagulative necrosis and probably other forms of cell death. group of cytotoxic agents have their maximum effects on
For all agents histological cell death becomes apparent cells in the area where the stem cells are presumed to be
within a few hours in many cases reaching a clear peak 3-9 located. All of the five agents, without exception, have been
hours after treatment. From studies with radiation it is clear shown to kill clonogenic cells and hence to destroy crypts
that the cells that die do not represent cells at a particular when the microcolony assay is used (Withers & Elkind, 1970;
stage of the cell cycle. This is clearly not the case with cell Moore, 1979, 1985; Hendry et at., 1984). However, several
cycle specific agents like hydroxyurea or vincristine. Radi- other agents which can sterilise crypts efficiently, i.e. BCNU
ation studies have also shown that some cells near the base and HN2 or sterilise crypts moderately efficiently, i.e. 5FU
of the crypt are extremely sensitive (Potten, 1977; Potten & and MTX, are found in other groups. ACT, CP, VCR and
Hendry, 1983; Ijiri & Potten, 1984). These may represent a HU cannot sterilise crypts when delivered as single doses
discrete subpopulation of the stem cells, possibly the ultimate (Moore, 1985).
stem cells (Potten, 1977) or merely the most sensitive compo- Thus, although there is not a precise one-to-one relation-
nent of a broad spectrum of sensitivities within the stem cell ship between histological cell death in the stem cell region
or clonogenic cell compartment (Hendry & Potten, 1982). and the reproductive sterilisation of crypts, there is a rough
Figure 6 summarises the results and conclusions, on the correlation. Recent studies have indicated that there are120 K. IJIRI & C.S. POTTEN
subtle differences in the circadian rhythms and repopulation alkylating agent seems to be in the same group as IMS
kinetics between the cells involved in histological death after (alkylating agent), ADR, BLM and radiation.
irradiation and those involved in clonogenicity. This has led If similar cellular hierarchies exist in tumours and the
to the suggestion that not all clonogenic cells are stem cells samc rclationships exist between the drugs studied herc and
(Potten & Hendry, 1975; Potten, 1977; Ijiri & Potten, 1986), the hierarchies, then one might speculate that the drugs that
a conclusion which is consistent with the observations pre- kill cells in the upper crypt might have good palliative
sented here. properties but poor curative ones in contrast with those
However, it should be recognised that some of the agents agents that kill cells near the bottom of the crypt. However,
used here which cause damage in the upper parts of the the basic assumption that all cytotoxic agents affect
crypt, but were not capable of killing crypts may cause more hierarchies in all tissues in a similar fashion (both normal
damage to the lower positions or damage clonogenic cells if tissues and tumour tissue) may not be valid. Studies in the
administered at other times of the day when, for example testis and the bone marrow with a range of cytotoxic agents
more of the stem cells are in S-phase. do not correlate precisely with those reported here (Meistrich
Here, the agents can be grouped into: Antibiotics (ADR, et al., 1982; Ijiri & Potten, 1987).
BLM, ACT, CH), radiation ([3H]TdR, y-ray), alkylating
agents (IMS, BCNU, CP, HN2, TEPA), antimetabolities
(5FU, HU, MTX) and a microtubule dissociating agent This work was supported by the Cancer Research Campaign (UK)
(VCR). Antibiotics on the whole and radiation would seem and the Ministry of Education, Science and Culture (Japan). We are
to attack the lower cell positions in the crypt. Some anti- grateful to Caroline Chadwick and Simon Tickle for their help with
biotics, e.g. BLM are often thought of as radiomimetic. these experiments and Dr J.V. Moore for his helpful comments.
Alkylating agents on the other hand to some extent act both
on the cells at the lower positions and also on cells higher up
the crypt i.e. they are rather variable or have a wide
spectrum of action. Antimetabolities seem to act on the Appendix A
higher cell positions which is to be expected since these
antimetabolities (5FU, HU, MTX) primarily affect DNA The reproducibility and reliability in the scoring ofthe distribution of
synthesis and many cells are in S-phase in the higher apoptoticfragments
positions (CH is often thought of as an antimetabolite). Twelve mice (10-12 weeks old) were divided into 3 groups, and each
Similarly VCR would be expected to attack higher cell group was treated and killed as follows: (4 mice, gamma-rays,
positions. In contrast, the lower cell positions should not be 0.5Gy, killed 3h), (4 mice, CP, 5.0mg, 6h) and (4 mice, HU,
very susceptible to these drugs because most of these cells 1.0mg, 3h). The experiment was repeated on each of four successive
are very slowly cycling (Potten & Hendry, 1983). However, weeks, thus providing 16 gamma-ray-treated, 16 CP-treated, and 16 arevendrygs
slo cycling (Potte
n &roup Hery
, 1gh. However, HU-treated mice. Fifty half-crypt sections were scored in each even drugs in thne same group may have slightly different mouse and the distributions of apoptotic fragments were determined
responses e.g. there is a wide range of differences in the from which the parameters (Xmed and Ur) were calculated. These
positions attacked by the various alkylating agents. IMS individual mouse values are plotted in the upper panels of Figure 7
tends to kill cells at lower cell positions, intermediate po- (open circles). The data from each of the four mice (i.e. for each
sitions (e.g. 6-8) are attacked by BCNU and CP, and cells at week) were pooled (200 half-crypt sections) and the parameters
relatively high positions (e.g. 8-9) are killed by HN2 and defining the distributions are shown in the lower panels in Figure 7
TEPA. CH disrupts the cellular metabolism, especially pro- (closed circles). In the same figure (double circles) all the distri-
tein synthesis acting at the translational level. The broad butions have been pooled (for the 16 mice, which correspond to
spreadin edistributions of apoptotic fragments after using 800 half-crypts). The data shown in Figure 7 were those scored by spread in the dscorer A (who was responsble for all of the other data in this
this drug indicates that crypt cells of a broad range of paper).
different hierarchical status die when their protein synthesis All the samples in Figure 7 were also scored by another scorer B
is inhibited by the dose of CH used here (5mg/mouse). and the median values of the distributions (the pooled data from 4
As seen in Figure 5 there is a characteristic spread (Ur) of mice) were compared in Figure 8. A crypt size correction was not
the distributions of apoptotic fragments, with most agents used in Figures 7 and 8, since the treatment and sampling times
having a ar value of between 4 and 5. However, CH and were identical for all 16 mice.
VCR produced a larger spread and some antimetabolities There is some scatter of the datum points in the upper panel of
(5FU and MTX) a smaller one. Thus although median Figure 7. This is presumably due to the small number of crypt
values might be similar the distributions may differ in shape. sections scored and individual mouse variations. In the lower panel
The conclusions on the position of the presumptive target in Figure 7 the deviatnonfrosftheeanpoptotic distributins presented
cells for MY and CDDP (Table II) must be regarded as here were obtained from 4 mice, scoring 200 half-crypts or more
preliminary, since most of the data were obtained only from (100 half-crypts when there were many apoptotic cells), the accuracy
selected crypts which had many apoptotic figures (Table I). of the median values reported should be within the same range i.e.
When a higher dose of MY was used (5.0mg) the mice died +0.5 cell positions.
within 6h. Heat (hyperthermia) also should be considered As seen in Figure 8, there was a good agreement between the two
separately. After heating, cells on the villus were also scorers. Initially time was spent consulting on the criteria to be
destroyed (Hume et al., 1979). In the present study dead adopted using a microscope with a double viewing head. Thereafter
cells were observed on the villus as well as in the crypts but there was no consultation. In fact the scoring was conducted by
celscweren observedtriton to the villusaserewell asdinethe apts scorer A in Japan and scorer B in the UK. The pooled data using the scoring was restricted to the crypts where cell death all 16 mice were used in the main part of this paper and are marked
was found to occur uniformly over all cell positions (see with an asterisk in Tables I and II.
Figure 4), i.e. these distributions were very broad with a large A comparison between the pure crystalline form of actinomycin D
spread. For example, the value of aJr for 3h after heat when (Sigma) and a more soluble clinical form (Cosmegen) was also
Xmdwas 8.4 (TbeII) was 9.2, aspread comparable to that conducted. No differences could be detected asis shown below:
after CH. From these reasons, MY, CDDP and heat have After 0.01mg there were 4.3 (Cosmegen) and 4.6 (Sigma)
been omitted from Figures 5 and 6. From Table II, Xmed for apoptotic cells per crypt section at 6h, and after 0.1mg 7.5
CDDP at t=0 (or 3h) seems to be 6, and probably this (Cosmegen) and 7.3 (Sigma). Xmed and Ur before crypt size
drug comes into the group with BCNU, 'ACT, CP ad CH. correction,iwhen expressed as (Xmed, a,), were (7.1, 4.7) (Cosmnegen)
For MY, from the normal appearance of the mitotic and (6.6, 4.5) (Sigma) after 0.1mg. After crypt size correction all the
apoptotic yields at 3 h and from the fact that the apoptotic Xmed values lay within the range of 7.2-7.7, and the ar values were
yield rises at 6h (Figure 3b), we believe that the Xmed value within the range 4.5-5.2. The number of mitotic figures per crypt
at t=3 h is most likely to give the value of the target cell section 6h after treatment were also similar: 1.3 (Cosmegen) and 1.4
distribution. As shown in Table II, the value is 4.9, and this (Sigma) after 0.01 mg, and 0.5 for both sources of ACT after 0.1 mg.RESPONSE OF INTESTINAL CRYPT CELLS TO CYTOTOXIC AGENTS 121
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Figure 7 An illustration of the scatter range in the parameters for the apoptotic distributions. The upper three panels show the
points (Xmed, Ur) of 16 individual mice for each of three treatments, i.e.-y-ray (0.5Gy, 3h), CP (5mg, 6h) and HU (Img, 3h)
repeated as four separate experiments conducted on each of four successive weeks. Fifty half-crypts were scored from each mouse.
The parameters for the pooled data from 4 mice (i.e. 200 half-crypts) are shown by the solid circles in the lower panels. The
parameters from the distribution for all 16 mice pooled (800 half-crypts) are shown by a double circle. See Appendix A.
10- The points Xmcd, Xmed+0.674Ur and Xmed+1.177Ur (Figure 2d) are employed in the present study to calculate the velocity. Although
HU these are merely arbitrary points on the distribution, the displace-
E E E ment of which with time can be measured, some arguments can be X 9 E put for using these parameters. The median was adopted because
C some distributions were skewed, in which case Xmed represents the
oP / central value (the peak point) better than the mean. (see Appendix in
the previous paper, Ijiri & Potten, 1983). Because the peak value
8 * (mode) on the actual distribution tends to fluctuate more than the
.- m / median the latter was again preferred. Xmed+0.674or and
.oa) / * Xmed+ 1.177ar represent points on the distribution at 3/4 of the total
o ° distribution and the half peak value respectively (Ijiri & Potten,
0 7- -ray 1983; Kaur & Potten, 1986).
The overall cell migration pattern in the crypt is complicated with
o 0 one pathway from the stem cells (at about cell position 4) to the
c * > O upper cell positions and another slower pathway from the stem cells
._6- ,' downwards to the Paneth cells. Since all the median values for
E / various cytotoxic agents were found to be more than 4, it can be
expected that the cell positions to the left of the median contain all,
or most, of the Paneth cells and this is not true for the positions to
5 6 7 8 9 10 the right of the median. In this paper the migration velocity of
apoptotic fragments is calculated from the displacement of the right
Median of apoptotic distribution Xmed (Scorer A) half of the distribution up ihe crypt with increasing time, i.e. only
the upward migration has been considered. On the assumption that Figure 8 Comparison of the median values of the distributions the right half is half of a normal distribution with the median as its
obtained by two different scorers. The same samples as in Figure peak and Ur as its standard deviation, the positions of the upper 1/4
7 were counted by two scorers A and B. Four points, each being (the upper quartile) of the total distribution, and the half-peak
from 4 mice (solid circle) and one point for the pooled data from position were theoretically given by Xmed+0.674¢Yr and Xmed+ 1.1 7Fr
16 mice (double circle) are shown for three treatments, i.e. y-ray respectively (Figure 2d). Having put z= (X-Xmcd)/ar, the following
(0.5 Gy, 3 h), CP (5mg, 6 h) and HU (1 mg, 3 h). The straight line stnarie nracuv wscoide:f()(/2re /2
at 45 shosth agremen beteen he to scres.The figure 0.674 was obtained when the area under the normal
curve to the right of this point is 25% of the total population, i.e.
Appendix B P(z._0.674) =0.25 or P(0._Z<0.674) =P(Z.0.674). The half-peak position was obtained solving the following equation: f(z)= f()/2,
Pointsonthedistributionusedforvelocity calculation which gave us z=2 ln =1.177. The movement of the half-peak
position has been used by others to assess the migration velocity of
The median (Xmcd) and a measure of the spread of the distribution the [3H]TdR-labelled cells in the crypts of rats and mice (Cairnie et
(ar and g1) are defined mathematically elsewhere (Ijiri & Potten, al., 1965; Wright et al......... 1974; Potten et al., 1982; Kaur & Potten,
1983) and can be used to characterise the apoptotic distributions. 1986).122 K. IJIRI & C.S. POTTEN
When the regression line is fitted to values of Xmed(t) over the
time interval from t=tl to t=t2, v expresses the average velocity
over the cell positions between Xmed(tl) and Xmed(t2), which
corresponds to the time interval between ti and t2. An average cell
position can be defined as Xmed((tI +t2)/2) as indicated by the letter
B in Figure 2c, and the value v can be plotted as the velocity at this
average position (shown in Figure 9). Here, three points on the
apoptotic distribution, i.e. Xmed, Xmed+0.674Ur and Xmed+ 1.177LTr
were chosen (Figure 2d). The velocities of the points Xmed+0.674ur
and Xmed + 1.177r were calculated in a similar manner as outlined
above for Xmcd.
Migration velocity ofapoptoticfragments in crypts treated with
cytotoxic agents
Some apoptotic fragments will be engulfed by neighbouring healthy
cells which if themselves in motion will carry the fragment up the
crypt. The velocity of such apoptotic fragments after the adminis-
tration of each cytotoxic agent was evaluated for each dose,
calculating the movement of three arbitrary points on the distri-
bution, namely Xmed, Xmed+0.674ar and Xmed+ 1.177Ur after crypt
size correction. The position of each of these points can then be
plotted against time after treatment and a regression line then can
be fitted (see Figures 2c and 2d). The dose and agent used for these
calculations are listed in the right-hand column of Table I and
marked with a +. In total, 28 doses of 18 agents were analysed.
Since three different points on the distribution were analysed a total
of 84 velocities estimates were obtained and are plotted in Figure 9.
Since the 84 data points are from 18 different cytotoxic agents,
whose modes of action, action time and levels of damage differ, the
data for each agent should really be looked at separately. However,
many unknown factors are involved and for the moment all 84
points will be considered together. The data covered most of the cell
positions in the crypt. The datum points were widely scattered but
were mostly within the range 0-0.5 cell positionsh-', with a
tendency to increase with increasing cell position.
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The data were subjected to a simple linear regression using least
squares. The resulting equation was v=0.0118x+0.0667, where v is
the velocity of migration (cell positionsh-1) and x the cell position.
The residual mean squares had a value of 0.0333, and the velocity,
with its 95% confidence interval at several cell positions, was as
follows: 0.126+0.022 (cell positionsh-1) at cell position 5,
0.173+0.020 at cell position 9, 0.206+0.020 at position 11.8 (where
the confidence limit is minimal), 0.220+0.020 at position 13, and
0.315+0.025 at position 21. As expected from the scattering of the
data, the coefficient of determination was low at r2 =0.046.
The migration velocity of apoptotic fragments (Figure 9) indicated
that there was a gradual shift to the right in the distributions of
apoptotic cells with time. This occurred in spite of the severe
cytotoxic damage, i.e. under conditions of reduced numbers of cells
in the crypt and reduced cell division activity. The apoptotic
fragments move probably because some are ingested by
neighbouring healthy cells, which themselves move up the crypt and
onto the villus. However, the velocities calculated here tend to be
lower than those calculated using [3H]TdR labelled cells. This is
probably due to the fact that: (1) some of the cytotoxic agents may
affect directly the mechanism involved in cell movement. (2) not all
apoptotic fragments are incorporated into migrating epithelial cells,
e.g. those engulfed by Paneth or stem cells or those lost to the crypt
lumen. (3) the general damage caused to the crypt by the cytotoxic
agents may result in severe structural damage to the crypt cells
(including peripheral fibroblast cells) so that cells can no longer
migrate normally.
For some agents, the velocity of the highest cell position with
apoptotic fragments (the leading edge of the distribution) was
estimated, using the 99th percentile point (i.e. the upper 1% point of
the distribution) in crypts where the size correction had been
applied. A regression line was then fitted as described in Figure 2
and the velocities were calculated. These were, HU (1.2 cellsh-1, at
cell position 26) and CP (0.9, at cell position 23). The data for IMS-
treated and y-ray-treated animals were 0.6cellsh-1 (at cell position
22) and 0.5 (at 20) respectively. These are similar to those reported
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Figure 9 Migration velocity of apoptotic fragments at different cell positions along the crypt column treated with various
cytotoxic agents. Eighty-four velocity values for various cell positions after treatment with 18 different agents are plotted. For each
dose level of an agent, the movement of three points on the distribution, i.e. Xmed, Xmed +0.674ar and Xmed + 1.177cr was traced
with time and the migration velocities were determined as described in Figures 2c and 2d. Thus, there are 3 or 6 points for each
agent (one or two dose levels). The abscissa (cell position) gives the average cell position determined as B in Figure 2c for Xmed,
and in a similar manner for other two points on the distribution. A simple linear regression was fitted to the velocity (v, cell
positions h-') vs. cell position (x), resulting in an equation v=0.0118x+0.0667 with its 95% confidence limit being within a
difference of +0.025 from the line over cell positions 5 to 21. The deviation of individual data from the regression line was
=0.183. Symbols as for Figures 4 and 5.
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for normal mice using the leading edge of the distributions of
[3H]TdR-labelled cells: 0.7 cell positionsh-1 at cell positions 18-25
(Potten et al., 1982), and 1.05 cell positionsh'- at cell position 24
(Cheng & Leblond, 1974) and - 1.5 cell positions h1- at cell position
20 (Kaur & Potten, 1986). These velocity estimates suggest that
those cells unaffected by the cytotoxic insult, near the top of the
crypt, continue to move in a near normal manner carrying any
engulfed fragments with them. This results in a broadening of the
distributions of apoptotic fragments (e.g. a broadening of ar) with
the passage of time.
VCR arrests cells in mitosis some of which will die and degenerate
and may appear pycnotic. No distinction has been made here
between pycnosis of arrested mitotic figures and apoptosis.
Occasionally it was difficult to distinguish arrested mitotic figures
from pycnotic mitotic figures but subjective criteria were established
to facilitate a discrimination between these two classes of mitotic
cells. Some clearly apoptotic cells were also observed as early as 3 h
after VCR, some of which were probably the consequence of the
direct action of VCR (Figure 3c). This was slightly more prominent
after a dose of 0.1 mg. Further differences between the results
obtained using two different doses of VCR were seen when various
times after treatment were studied. After 0.01 mg the number of
mitotic cells decreased with time (from 3 to 12h), while the number
of apoptotic cells increased up to 9h (probably due to degeneration
from the arrested metaphases). The apoptotic yield then decreased
(presumably due to the disappearance of the degenerating cells).
Similar results have been reported after VCR treatment of mouse
ascites tumour cells (Camplejohn et al., 1980). After the higher dose
(0.1 mg) the number of mitotic figures remained constant over the
period 3-12h post-treatment, while there was a continuous increase
in the number of apoptotic cells (Figure 3c). After the high dose of
VCR new metaphases may continue to be arrested even after times
greater than 3h. However, the possibility cannot be excluded that
the discrepancy in the results when the two doses are compared may
be due to the difficulty in distinguishing mitotic figures from
apoptotic cells. For this reason the combined distributions of mitotic
figures and apoptotic fragments were analysed for the study on cell
movement (the leading edge). For 0.01 mg VCR this was
0.7cellsh- I at cell position 26, and for 0.1 mg VCR, 0.5cellsh' at
cell position 26.
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